InvestorsHub Logo

brezlin

11/10/20 7:19 PM

#42220 RE: OTCShotCaller #42218

Thank you OTC.... I think we all hope that after MERGER finalized, New Name and ticker (IF) settled etc., we’ll start seeing a steady stream of information outlining targets and goals, hopefully A Big Pharm partner and some funding. That happens and I believe you will be correct, $ to $$. Hoping by next summer anyway.

Buyout always a possibility after established a little too. If so I don’t imagine it’ll go cheap...

southswell7

11/10/20 7:28 PM

#42223 RE: OTCShotCaller #42218

Great post, and we have Covid treatments

About BioClonetics Immunotherapeutics, Inc.
BioClonetics Immunotherapeutics, Inc. is a Dallas Texas biotech company with plans to merge with Enzolytics. BioClonetics has developed a proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases including HIV, rabies, influenza A, influenza B, tetanus, and diphtheria. Its proprietary methodology for producing fully human monoclonal antibodies may be used to produce therapeutics treatments for many infectious diseases including the Coronavirus.

BluE33

11/10/20 11:41 PM

#42237 RE: OTCShotCaller #42218

Company needs to be current and have the merger completed...in addition to having a new ticker symbol and name change which I believe they hinted in today’s PR!

$ENZC